BR112015029987A2 - beta-caseína a2 e a prevenção de inflamação do intestino - Google Patents

beta-caseína a2 e a prevenção de inflamação do intestino

Info

Publication number
BR112015029987A2
BR112015029987A2 BR112015029987A BR112015029987A BR112015029987A2 BR 112015029987 A2 BR112015029987 A2 BR 112015029987A2 BR 112015029987 A BR112015029987 A BR 112015029987A BR 112015029987 A BR112015029987 A BR 112015029987A BR 112015029987 A2 BR112015029987 A2 BR 112015029987A2
Authority
BR
Brazil
Prior art keywords
prevention
beta
beta casein
casein
bowel inflammation
Prior art date
Application number
BR112015029987A
Other languages
English (en)
Other versions
BR112015029987A8 (pt
Inventor
John Clarke Andrew
Original Assignee
A2 Milk Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51989162&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112015029987(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by A2 Milk Co Ltd filed Critical A2 Milk Co Ltd
Publication of BR112015029987A2 publication Critical patent/BR112015029987A2/pt
Publication of BR112015029987A8 publication Critical patent/BR112015029987A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Confectionery (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1/1 resumo “beta-caseína a2 e a prevenção de inflamação do intestino” a presente invenção refere-se ao uso de uma composição para prevenir ou reduzir o risco de inflamação do intestino em um animal, em que a composição contém beta­caseína e em que a beta-caseína compreende pelo menos 50% em peso de beta­caseína a2
BR112015029987A 2013-05-31 2014-05-30 Beta-caseína a2 e a prevenção de inflamação do intestino BR112015029987A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361829764P 2013-05-31 2013-05-31
PCT/NZ2014/000102 WO2014193248A1 (en) 2013-05-31 2014-05-30 Beta-casein a2 and prevention of inflammation of the bowel

Publications (2)

Publication Number Publication Date
BR112015029987A2 true BR112015029987A2 (pt) 2017-07-25
BR112015029987A8 BR112015029987A8 (pt) 2021-12-07

Family

ID=51989162

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015029987A BR112015029987A8 (pt) 2013-05-31 2014-05-30 Beta-caseína a2 e a prevenção de inflamação do intestino

Country Status (20)

Country Link
US (2) US20160113997A1 (pt)
EP (2) EP3003485B1 (pt)
JP (2) JP6867158B2 (pt)
KR (2) KR102282972B1 (pt)
CN (2) CN112316116A (pt)
AU (2) AU2014271423B2 (pt)
BR (1) BR112015029987A8 (pt)
CA (1) CA2913890A1 (pt)
CL (1) CL2015003507A1 (pt)
DK (1) DK3003485T3 (pt)
ES (1) ES2742306T3 (pt)
HK (1) HK1222362A1 (pt)
IL (2) IL242833B (pt)
MX (2) MX367794B (pt)
MY (1) MY179497A (pt)
PH (2) PH12015502674B1 (pt)
RU (1) RU2669553C2 (pt)
SG (2) SG11201509769QA (pt)
WO (1) WO2014193248A1 (pt)
ZA (1) ZA201508983B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102282972B1 (ko) * 2013-05-31 2021-07-28 디 에이2 밀크 컴퍼니 리미티드 베타­카세인 ａ2 및 창자의 염증 예방
GB2519101A (en) * 2013-10-09 2015-04-15 Nicoventures Holdings Ltd Electronic vapour provision system
CN106455662A (zh) * 2014-06-03 2017-02-22 雅培制药有限公司 包含亲脂性活性成分的营养组合物
CN107708711A (zh) * 2015-05-22 2018-02-16 艾尔牛奶有限公司 β‑酪蛋白A2和抗氧化能力
WO2017003300A1 (en) * 2015-06-29 2017-01-05 The A2 Milk Company Limited A2 beta-casein and viscosity of milk products
ES2886647T3 (es) 2016-03-30 2021-12-20 A2 Milk Co Ltd Betacaseínas y función cognitiva
JP6873234B2 (ja) * 2016-09-30 2021-05-19 ズィ・エイツー・ミルク・カンパニー・リミテッド ベータカゼイン類および腸微生物叢
CN109563049B (zh) * 2016-10-14 2022-11-29 豪夫迈·罗氏有限公司 作为eaat3抑制剂的咪唑化合物
NL2019906B1 (en) * 2017-11-14 2019-05-20 Ausnutria Hyproca B V Composition comprising a2 b-casein and a vegetable fat mixture
CN112205476A (zh) * 2019-07-11 2021-01-12 北京三元食品股份有限公司 β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用
WO2021003741A1 (zh) * 2019-07-11 2021-01-14 北京三元食品股份有限公司 β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用
CN115708530A (zh) * 2022-11-15 2023-02-24 北大荒完达山乳业股份有限公司 一种促进消化舒适性并稳定血糖的孕产妇配方奶粉及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6451368B1 (en) 1994-04-11 2002-09-17 New Zealand Dairy Board Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected
NZ306584A (en) * 1995-05-16 2000-02-28 Corran Norman Stuart Mclachlan Milk or dairy products derived from animals and which are free of beta casein
AU4266100A (en) * 1995-05-16 2000-10-12 Corran Norman Stuart Mclachlan Food product and process
US6570060B2 (en) 1995-05-16 2003-05-27 Mclachlan Corran Norman Stuart Milk lacking β-casein A1
ATE297125T1 (de) 1995-05-16 2005-06-15 A2 Corp Ltd Nahrungsmittel und herstellungsverfahren
NZ516712A (en) * 1999-06-29 2003-10-31 New Zealand Milk Inst Ltd Prophylactic dietary supplement based on milk
CN1159984C (zh) * 1999-06-29 2004-08-04 新西兰奶制品研究所有限公司 基于奶的预防性饮食添加剂
WO2002019832A1 (en) 2000-09-08 2002-03-14 New Zealand Dairy Board MILK CONTAINING β-CASEIN WITH PROLINE AT POSITION 67 DOES NOT AGGRAVATE NEUROLOGICAL DISORDERS
EP1420811A2 (en) * 2001-04-10 2004-05-26 Societe Des Produits Nestle S.A. Method and composition for prophylaxis of diabetes
US20060280802A1 (en) 2002-10-04 2006-12-14 Campbell Julie H Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2
US7481127B2 (en) 2004-09-27 2009-01-27 Lester William T Continuously variable transmission using oscillating torque and one-way drives
EP2068908B1 (en) * 2006-10-06 2014-07-16 Kerry Group Services International Limited A milk protein composition and use thereof
US8871276B2 (en) * 2008-02-11 2014-10-28 Technion Research And Development Foundation Ltd. Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents
TWI516269B (zh) * 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病（ｉｂｄ）治療和預防之透明質酸混合物
KR102282972B1 (ko) * 2013-05-31 2021-07-28 디 에이2 밀크 컴퍼니 리미티드 베타­카세인 ａ2 및 창자의 염증 예방

Also Published As

Publication number Publication date
DK3003485T3 (da) 2019-08-19
BR112015029987A8 (pt) 2021-12-07
RU2015153113A (ru) 2017-07-05
IL262302B (en) 2021-02-28
KR20160024884A (ko) 2016-03-07
EP3542813A1 (en) 2019-09-25
CN112316116A (zh) 2021-02-05
RU2018131733A (ru) 2018-11-08
ZA201508983B (en) 2017-11-29
JP2019165746A (ja) 2019-10-03
IL262302A (en) 2018-11-29
AU2014271423B2 (en) 2018-12-20
EP3003485A1 (en) 2016-04-13
SG11201509769QA (en) 2015-12-30
PH12015502674A1 (en) 2016-03-07
CN105407971A (zh) 2016-03-16
MX2019010594A (es) 2019-10-15
EP3003485B1 (en) 2019-05-15
HK1222362A1 (zh) 2017-06-30
AU2014271423A1 (en) 2015-12-24
AU2018274937B2 (en) 2020-10-29
WO2014193248A1 (en) 2014-12-04
JP2016520611A (ja) 2016-07-14
IL242833B (en) 2019-07-31
KR102282972B1 (ko) 2021-07-28
JP6867158B2 (ja) 2021-04-28
RU2018131733A3 (pt) 2021-10-29
ES2742306T3 (es) 2020-02-13
US20200179485A1 (en) 2020-06-11
PH12015502674B1 (en) 2016-03-07
EP3003485A4 (en) 2016-11-30
NZ714912A (en) 2021-06-25
US11911439B2 (en) 2024-02-27
MX367794B (es) 2019-09-06
CN105407971B (zh) 2020-11-17
KR102402455B1 (ko) 2022-05-25
US20160113997A1 (en) 2016-04-28
PH12019550096A1 (en) 2020-02-10
KR20210094674A (ko) 2021-07-29
MX2015016493A (es) 2016-08-18
CA2913890A1 (en) 2014-12-04
RU2669553C2 (ru) 2018-10-12
JP7224242B2 (ja) 2023-02-17
AU2018274937A1 (en) 2019-01-03
CL2015003507A1 (es) 2016-12-16
MY179497A (en) 2020-11-09
SG10201709509RA (en) 2017-12-28

Similar Documents

Publication Publication Date Title
BR112015029987A2 (pt) beta-caseína a2 e a prevenção de inflamação do intestino
BR112017017217A2 (pt) ?composição que compreende ramnolipídeo e siloxano?
BR112018006368A2 (pt) composição para desempenho melhorado
DOP2016000125A (es) MODULADORES DE ROR GAMMA (RORy)
BR112016008409A2 (pt) Uso de um agente inibidor de masp-2 que inibe a ativação de complemento dependente de masp-2
BR112015021352A2 (pt) composições antimicrobianas
BR112015021665A2 (pt) misturas de isômeros de (metilciclohe-xil)tolueno, sua produção e uso na fabricação de plastificantes
BR112015025787A8 (pt) composição para o tratamento e/ou pós-tratamento do câncer e uso de uma combinação de óleo de peixe e suco na fabricação de tal composição
BR112016000612B8 (pt) Uso de leite na fabricação de uma composição para prevenir ou reduzir os sintomas de intolerância a lactose
UY35276A (es) Nuevos compuestos que inhiben la actividad de Lp-PLA2
BR112016007068A2 (pt) ?composições cosméticas?
BR112015032029A2 (pt) uso de uma composição compreendendo óleo de peixe e suco para o tratamento de inflamação
BR112015030774A2 (pt) novos compostos para o tratamento de câncer
BR112015032339A8 (pt) Composição resistente à água
BR112018068817A2 (pt) beta-caseínas e função cognitiva
CL2016001098A1 (es) Uso de cisteamina y sus derivados para el tratamiento de enfermedades mitocondriales
BR112015018180A2 (pt) composição estereoisomérica de difenoconazol com fitotoxicidade reduzida
BR112014018850A8 (pt) Composição e sua utilização no tratamento de rágades anais
BR112016012552A8 (pt) derivado de cromona como um antagonista do receptor d3 de dopamina, seu uso e sua composição farmacêutica
AR097143A1 (es) Composición alimenticia mineral para lamer para rumiantes y método para prepararla
BR112014022921B8 (pt) Composição farmacêutica compreendendo veneno paralizante de moluscos e uso do mesmo.
BR112013030308A2 (pt) composição de oligossacarídeos para prevenir ou reduzir o risco de síndrome metabólica
BR112019008389A2 (pt) novas composições ativas em adipócitos
BR112018010442A8 (pt) ?composição antimicrobiana, método de inibição do crescimento microbiano e uso de composição?
BR112018001157A2 (pt) profilaxia da hipertensão e doenças cardiovasculares

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B350 Update of information on the portal [chapter 15.35 patent gazette]
B25G Requested change of headquarter approved

Owner name: THE A2 MILK COMPANY LIMITED (NZ)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]